incb001158
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Nov 20, 2017 (NCT03314935)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Arginase-1INHIBITOR
ARG1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03910530 | Phase 1 | Jul 31, 2019 | Incyte |
| NCT03837509 | Phase 1/Phase 2 (Phase 2) | Jun 30, 2019 | Incyte |
| NCT03361228 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2018 | Incyte |
| NCT03314935 | Phase 1/Phase 2 (Phase 2) | Nov 20, 2017 | Incyte |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Incyte | For profit | 4 | 4 | 2 | 2017 |
1 organizations
Page 1 / 1